United States · FDA National Drug Code directory
Copaxone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68546-325_11a58ba0-b865-49e6-86e3-eb9bb58341e5
- Product NDC
- 68546-325
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Glatiramer Acetate
- Labeler
- Teva Neuroscience, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140129
- Source listing expiry
- 20271231
Source-listed ingredients
- GLATIRAMER ACETATE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (68546-325-06) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS · 68546-325-06
- 12 BLISTER PACK in 1 CARTON (68546-325-12) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS · 68546-325-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →